ConductScience.org, home

Paper42920161PubMed

Advancing women's health in Egypt: an economic evaluation of the presidential initiative for nationwide breast cancer early detection and treatment.

Abdelghaffar K and 18 others. Arch Public Health, 2026.

Cite this record

ConductScience Library. Advancing women's health in Egypt: an economic evaluation of the presidential initiative for nationwide breast cancer early detection and treatment. Papers, record 42920161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42920161

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advancing women's health in Egypt: an economic evaluation of the presidential initiative for nationwide breast cancer early detection and treatment.
Journal
Arch Public Health
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-26

Source PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abdelghaffar KKhaled
2Hassany MMohamed
3Elghazaly HHesham
4Amin HHatem
5Morsi AAhmed
6Shash EEmad
7Abdelaziz AHAhmed H
8Kassem LLoay
9Omar NNany
10Shaltout DDalia
11Mostafa SMSalma Mohamed
12Ashraf AAlaa
13Awad MABMohamed Abo Bakr
14Bendary RERana Elsayed
15Khalil HHowaida
16Gazar SSalwa
17Atef BBassant
18Ibrahim AAhmed
19Anan IIslamhttps://orcid.org/0000-0002-0697-6464

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127165206Incidence and Mortality and Epidemiology of Breast Cancer in the World.Asian Pac J Cancer Prev2016https://conductscience.org/library/papers/27165206PubMed
239665251
The cost-effectiveness of treatment for high-risk, early-stage, triple-negative breast cancer in Egypt: an analysis of neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant single-agent pembrolizumab.
J Med Econ2025https://conductscience.org/library/papers/39665251PubMed
327814965The global burden of women's cancers: a grand challenge in global health.Lancet2017https://conductscience.org/library/papers/27814965PubMed
421037243Health outcomes in economic evaluation: the QALY and utilities.Br Med Bull2010https://conductscience.org/library/papers/21037243PubMed
540669034Breast Cancer in the Middle East and North Africa: Economic Burden, Market Trends, and Care Challenges.JCO Oncol Pract2026https://conductscience.org/library/papers/40669034PubMed
633559295The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low- and middle-income countries and the MENA region.Int J Cancer2021https://conductscience.org/library/papers/33559295PubMed
739618259The indirect costs of five cancers in Egypt: years of life lost and productivity costs.J Med Econ2025https://conductscience.org/library/papers/39618259PubMed
828294295Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.CA Cancer J Clin2017https://conductscience.org/library/papers/28294295PubMed
926495294Breast cancer by age at diagnosis in the Gharbiah, Egypt, population-based registry compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008.Biomed Res Int2015https://conductscience.org/library/papers/26495294PubMed
1012558355Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.Ann Intern Med2003https://conductscience.org/library/papers/12558355PubMed
1132011199Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt.J Med Econ2020https://conductscience.org/library/papers/32011199PubMed
1240240430Regional differences in the disease burden and attributable risk factors of female cancers.Sci Rep2025https://conductscience.org/library/papers/40240430PubMed
1329626738Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.Value Health Reg Issues2018https://conductscience.org/library/papers/29626738PubMed
1422999130State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3.Value Health2012https://conductscience.org/library/papers/22999130PubMed
1533655849Recent Advances in Diagnostic and Therapeutic Approaches for Breast Cancer: A Comprehensive Review.Curr Pharm Des2021https://conductscience.org/library/papers/33655849PubMed
1634923225The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis.Breast2022https://conductscience.org/library/papers/34923225PubMed
1725328522Cancer incidence in egypt: results of the national population-based cancer registry program.J Cancer Epidemiol2014https://conductscience.org/library/papers/25328522PubMed
1823322203Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study.Br J Cancer2013https://conductscience.org/library/papers/23322203PubMed
1920533039Cost-effectiveness of clinical breast assessment-based screening in rural Egypt.World J Surg2010https://conductscience.org/library/papers/20533039PubMed
2028190381Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review.Palliat Med2017https://conductscience.org/library/papers/28190381PubMed

See all 57 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42920161

GET https://conductscience.org/api/papers/v1/42920161/references?page=2